Français | English

Agence nationale sanitaire et scientifique en cancérologie

Accueil The French National Cancer Institute Presentation L'INCa

Partager
  Print Imprimer

 

A Health and Science Agency: Expertise, Objectives and Resources

Created by the Public Health Law of 9 August 2004, INCa has two core objectives:

  • to develop expertise in the field of cancer
  • and to provide scientific planning, evaluation and funding for projects.

Pascale Flamant is the acting Chair and Managing Director of INCa.

An Advisory Agency

INCa is the point of reference for cancer pathologies within State or State-affiliated public institutions. Therefore, it must share its cancer expertise with government departments and health insurance offices, as well as other public scientific and technological agencies and institutions (EPSTs).


INCa develops expertise by producing, co-producing or participating in various ways in normative documents:

  • An Advisory Agency
  • Collective Expertise
  • Patient Advice
  • Certification Criteria
  • Regulatory texts and official circulars (e.g.: specifications for organised colorectal cancer screening, a regulatory system for healthcare facility approval, circulars about the regional oncology networks).

An Agency of Objectives and Resources

In terms of scientific planning, funding and evaluation of projects, INCa is the agency of objectives and resources dedicated to cancer research.

INCa devotes half of all its funding (approximately € 50 million) to research.

It launches two calls for proposals a year for specific pathologies (early forms of colorectal cancer, etc.) and/or specific fields (from genomics to patient quality of life) as well as other open calls for proposals. It receives several hundred proposals a years, from which it selects around 30%.

 

The Institute also launches calls for joint projects with major non-profit organisations: such as the Integrated Research & Action Programme for prostate cancer (PAIR prostate) in 2009 with the French Cancer Research Association (ARC) and the French National Cancer League.

On behalf of the Directorate-General for Healthcare (DGOS), the institute also runs the Hospital Cancer Clinical Research Programme (PHRC Cancer) and the Programme to Support Innovative and Costly Cancer Techniques (STIC Cancer).

A Collaborative Effort

INCa works in partnership with other public and private entities.
In this capacity it enters into agreements, including framework agreements, with other institutions in order to harness competencies (methodology and expertise) for shared projects and also to publish guides for GPs and patients or to support technological and organisational advances designed to improve quality in cancer treatment and information.

Partners in INCa’s Public Interest Group (GIP):

INCa and the 2009-2013 Cancer Plan

The National Cancer Institute is in charge of 63 of the 118 actions in the Cancer Plan, along with all of the partners involved.
It is responsible for overseeing the implementation of the 30 measures and 118 actions in the 2009-2013 Cancer Plan. INCa also collects data from 15 other action coordinators. It analyses and applies the data and organises interministerial steering committee meetings with the Directorate-General for Health. It brings together all actors and users in the monitoring of the plan via its Board of Directors, the committee for patients, friends and family and users (CMPU) and the healthcare professional advisory board (CCPS).

Agreement on Objectives and Performance

The National Cancer Institute has signed its first agreement on objectives and performance with the Ministries of Health and Research for the period of 2011-2014.
This AOP was approved by the Board of Directors of GIP INCa on 17 December 2010.

Six strategic objectives are set for INCa, accompanied by around thirty monitoring indicators to measure their level of achievement annually. The six objectives are the following:

  • Ensure a better coordination between the different players in the fight against cancer in order to reach the final common goals;
  • Produce a quality expertise by the analysis and synthesis of scientific data on cancer and oncology;
  • Encourage scientific, technological and organisational innovation and promote its publication and distribution;
  • Promote the taking on board of assessment results and innovations by the general public, patients, health professionals and researchers;
  • Ensure, on behalf of public authorities, the monitoring of the implementation of the 2009-2013 Cancer Plan;
  • Enhance the institution’s efficiency.

This agreement is consistent with the objectives and priorities set by the 2009-2013 Cancer Plan.

 

Download INCa's AOP (in French) icon le contrat d'objectifs et de performance (887.33 KB) de l'INCa.

Delegation of Signature

As part of the modernisation of administrative and financial procedures, a system of delegation of signature was put in place (legal act by which an authority delegates the power to sign documents and acts strictly enumerated in the delegation, to a third person) by Pascale Flamant, Acting Chair, to department directors and managers for a number of acts: public contract, travel order, certification of reports.

 

 


Ce site respecte les principes de la charte HONcode.
Vérifiez ici.